Helus Pharma Inc. (HELP) Form 6-K — Nov 3, 2026

$HELPForm 6-KFiled Nov 3, 2026, 11:23 AM ET0001062993-26-005696Original filing

Helus Pharma (Nasdaq: HELP) announced that CEO Michael Halstead will participate in a fireside chat at the Guggenheim Healthcare Innovation Conference in Boston on November 9, 2026 at 3:00 p.m. EDT. The chat will be webcast live, with a replay available on the company's investor relations site. Helus Pharma is a clinical-stage company developing novel serotonergic agonists for mental health conditions.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $40.67/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.